-13.8%
ETHA vs GSK
+3.0%
-16.8%
-32.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | +0.5% | -3.9% | -3.3% |
| 7D | -12.5% | +1.1% | -13.7% | -12.5% |
| 30D | -19.8% | +6.3% | -26.1% | -19.7% |
| 3M | +3.1% | +1.8% | +1.3% | +3.2% |
| 6M | -13.8% | +1.7% | -15.4% | -14.4% |
| All | -13.8% | +3.0% | -16.8% | -14.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling